{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:33:19Z","timestamp":1793118799546,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,15]]},"abstract":"<jats:p>Heart failure and diabetes mellitus are 2 common and closely intertwined chronic conditions that often coexist in individuals. The relationship between heart failure and diabetes is bidirectional, meaning that each condition can influence the development and progression of the other. Understanding this complex interplay is crucial for optimizing the management and outcomes of patients with these comorbidities. This review comprehensively analyzed the literature to examine the bidirectional relationship between heart failure and diabetes. We searched various electronic databases and included studies that explored the pathophysiological mechanisms, epidemiology, clinical implications, and therapeutic considerations associated with this relationship. The bidirectional relationship between heart failure and diabetes is multifactorial and involves several interconnected mechanisms. Diabetes is a recognized risk factor for heart failure, increasing the risk of its development and accelerating its progression. On the other hand, heart failure can contribute to the development of insulin resistance and worsen glycemic control in patients with diabetes. Shared risk factors, such as obesity, hypertension, and dyslipidemia, contribute to development of both conditions. Additionally, hyperglycemia, insulin resistance, chronic inflammation, oxidative stress, and mitochondrial dysfunction play significant roles in the pathogenesis of heart failure in individuals with diabetes. The bidirectional relationship between heart failure and diabetes has important clinical implications. Patients with heart failure and diabetes have worse outcomes, including higher hospitalization rates, morbidity, and mortality, than those without diabetes. Optimal management strategies should target both conditions simultaneously, focusing on lifestyle modifications, pharmacotherapy, glycemic control, and cardiovascular risk reduction.<\/jats:p>","DOI":"10.1097\/md.0000000000034906","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:20:28Z","timestamp":1694827228000},"page":"e34906","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":48,"title":["Heart failure and diabetes: Understanding the bidirectional relationship"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0249-1865","authenticated-orcid":false,"given":"Chukwuka","family":"Elendu","sequence":"first","affiliation":[{"name":"Federal University Teaching Hospital, Owerri, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dependable C.","family":"Amaechi","sequence":"additional","affiliation":[{"name":"Igbinedion University Okada, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tochi C.","family":"Elendu","sequence":"additional","affiliation":[{"name":"Imo State University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manizha","family":"Ashna","sequence":"additional","affiliation":[{"name":"University of Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ross-Comptis","sequence":"additional","affiliation":[{"name":"Larkin Community Hospital, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra O.","family":"Ansong","sequence":"additional","affiliation":[{"name":"Catholic Hospital Battor, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel O.","family":"Egbunu","sequence":"additional","affiliation":[{"name":"Federal Medical Centre Bida, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine C.","family":"Okafor","sequence":"additional","affiliation":[{"name":"University of Nigeria Teaching Hospital, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klein A.","family":"Jingwa","sequence":"additional","affiliation":[{"name":"Kazan State Medical University, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinbayo A.","family":"Akintunde","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidinma M.","family":"Ogah","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa O.","family":"Edeko","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodeji V.","family":"Ibitoye","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojetoluwa O.","family":"Ogunseye","sequence":"additional","affiliation":[{"name":"Nationa Pirogov Memorial Medical University, Vinnytsia, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisom E.","family":"Alakwe-Ojimba","sequence":"additional","affiliation":[{"name":"Chukwuemeka Odumegwu Ojukwu University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice K.","family":"Omeludike","sequence":"additional","affiliation":[{"name":"University of Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibuike A.","family":"Oguine","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rechner N.","family":"Afuh","sequence":"additional","affiliation":[{"name":"The Manor Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton A.","family":"Olawuni","sequence":"additional","affiliation":[{"name":"General Hospital, Odan, Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyekachukwu R.","family":"Ekwem","sequence":"additional","affiliation":[{"name":"Delta State University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boluwatife A.","family":"Oyedele","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica I.","family":"Pius","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy O.","family":"Asekhauno","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Ladele","sequence":"additional","affiliation":[{"name":"Babcock University, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinonso B.","family":"Okoro","sequence":"additional","affiliation":[{"name":"Federal medical center Owerri, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon C.","family":"Monika Pouekoua","sequence":"additional","affiliation":[{"name":"University of Bamenda, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Adenikinju","sequence":"additional","affiliation":[{"name":"Northwick Park Hospital London Northwest NHS Trust, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chigozirim M.","family":"Agu-ben","sequence":"additional","affiliation":[{"name":"Kharkiv Nationa Medical University, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ooreofe","family":"Aborisade","sequence":"additional","affiliation":[{"name":"Olabisi Onabanjo University Teaching Hospital, Nigeria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure.","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study.","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update.","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabetes Care"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited.","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2337\/diacare.26.8.2433","article-title":"Heart failure: the frequent, forgotten, and often fatal complication of diabetes.","volume":"26","author":"Bell","year":"2003","journal-title":"Diabetes Care"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1179546818809358","DOI":"10.1177\/1179546818809358","article-title":"Moving from heart failure guidelines to clinical practice: gaps contributing to readmissions in patients with multiple comorbidities and older age.","volume":"12","author":"Iyngkaran","year":"2018","journal-title":"Clin Med Insights Cardiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1479164112471064","article-title":"Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology.","volume":"10","author":"Cubbon","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American heart association and the heart failure society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update.","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure.","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCHEARTFAILURE.108.794008","article-title":"Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland.","volume":"1","author":"MacDonald","year":"2008","journal-title":"Circ Heart Fail"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","article-title":"Metabolic impairment in heart failure: the myocardial and systemic perspective.","volume":"64","author":"Doehner","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure.","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation.","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study.","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pcad.2016.01.008","article-title":"Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated.","volume":"58","author":"Lavie","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","article-title":"Insulin signaling and heart failure.","volume":"118","author":"Riehle","year":"2016","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"R19-20250504","first-page":"S15","article-title":"2. classification and diagnosis of diabetes: standards of medical care in diabetes-2021.","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines.","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"R22-20250504","first-page":"S151","article-title":"11. microvascular complications and foot care: standards of medical care in diabetes-2021.","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart association task force on clinical practice guidelines and the heart failure society of America.","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease.","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R25-20250504","first-page":"S168","article-title":"12. Older adults: standards of medical care in diabetes-2021.","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure.","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/0002-9149(93)90582-W","article-title":"Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo.","volume":"71","author":"Rector","year":"1993","journal-title":"Am J Cardiol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline.","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","article-title":"2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American college of cardiology solution set oversight committee.","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Meta-analysis global group in chronic heart failure. predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure.","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/CIRCULATIONAHA.108.813493","article-title":"Heart failure after acute myocardial infarction: a lost battle in the war on heart failure?","volume":"118","author":"Jhund","year":"2008","journal-title":"Circulation"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/dci17-0052","article-title":"Heart failure: the most important, preventable, and treatable cardiovascular complication of type 2 diabetes.","volume":"41","author":"Packer","year":"2018","journal-title":"Diabetes Care"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R35-20250504","first-page":"S125","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes-2021.","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"DAPA-HF trial committees and investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction.","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes.","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"ESC Scientific Document Group. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease.","volume":"98","year":"2020","journal-title":"Kidney Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:45:50Z","timestamp":1746326750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":39,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034906","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}